|
Active metabolites predicted to be lowered in Jurkat cells |
| Previously known anticancer activity in Jurkat cells |
|
|
| thymidine (C00214)1 |
| prostaglandin D2 (C00696) |
| Anticancer activity in Jurkat cells tested in this work |
|
|
| riboflavin (C00255) |
| tryptamine (C00398) |
| 3-sulfino-L-alanine (C00606) |
| menaquinone (C00828) |
| dehydroepiandrosterone sulfate (C04555) |
| α-hydroxy fatty acid (C05102) |
| hydroxyacetone (C05235) |
| seleno-L-methionine (C05335) |
| α-ribazole (C05775) |
|
1 KEGG ligand identifier |
Arakaki et al. Molecular Cancer 2008 7:57 doi:10.1186/1476-4598-7-57 |